Are you a CIPA member?
Sign in to your account to register for the event
If you are not yet registered or a member of CIPA, please register here
- News
- News
- NewsMedia
- Events
- Events
- EventsIntroductory Patent Paralegal CourseAdvanced Patent Paralegal Course (APPC)
- Advice
- Advice
- IP explainedResources
- Members
- Members
- MembershipBrand & Marketing Materials
- Publications
- Publications
- Online ShopCIPA JournalDownloads
- Jobs
- About Us
×Event Listing
CRISPR IP Considerations
30Jun
Webinar CRISPR IP Considerations
Tuesday 30 June
Location
Ever wondered why CRISPR is at the forefront of multiple patent interferences in the US and contentious proceedings before the EPO? This webinar will explain for those not familiar with the technology why there is such interest, will give a short overview of the IP battles aimed at all patent attorneys and, for those working in life sciences, will finish with some considerations when drafting in this field.
Audience
Fellows, Students
Speakers
Catherine Coombes, Haseltine Lake KempnerCatherine Coombes, Haseltine Lake Kempner
Cath has spent 20 years in private practice protecting client’s technology across life sciences prior to joining HLK and is known to provide personable, pragmatic, strategic and commercially focused IP advice in areas such as large scale pharmaceuticals, gene editing, food ingredients, plant biotechnology, sequencing, and drug delivery.
A CRISPR specialist, Cath has worked on some of the earliest CRISPR patents exploiting its role in bacterial immunity and has been at the forefront on this technology ever since. As such, Cath has extensive experience in opposition matters, due diligence, and drafting across the wide array of technologies to which CRISPR has been applied. Cath has provided education to fellow patent attorneys, has written numerous articles and has provided commentary on CRISPR IP to leading scientific and IP journals such as Nature, Science, The Scientist, IAM and LSIPR.
Prior to joining the IP profession Cath’s background was in the scale up of active pharmaceutical ingredients and in the downstream processing of food ingredients.
Shopping Bag (0)